Enochian Biosciences Inc. (ENOB)
NASDAQ: ENOB
· Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM
Enochian Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
PE Ratio | 557.78 | -14.5 | -2.3 | 0.00 | -1.2 | -0.00 | -0.00 | -0.00 | -3.14 | -3.07 | -0.14 | -17.51 | -14.49 | -8.44 | -3.56 | -10.27 | -11.73 | -17.4 |
PEG Ratio | -5.42 | 0.17 | 0.02 | -0.00 | -0.00 | n/a | -0.00 | -0.00 | 0.07 | 0.03 | -0.00 | 2.28 | 0.41 | 0.20 | -0.01 | -0.28 | -0.52 | 0.42 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.78 | 5.13 | 4.15 | 1.90 | n/a | 0.00 | 0.00 | 0.77 | 0.85 | 1.42 | 1.40 | 2.69 | 2.30 | 2.10 | 1.41 | 1.02 | 0.85 | 1.02 |
P/FCF Ratio | -283.75 | -164.37 | -201.89 | 0.00 | n/a | n/a | -0.00 | -15.49 | -16.77 | -35.36 | -33.23 | -155.95 | -82.55 | -66.54 | -18.9 | -71.05 | -54.91 | -60.55 |
P/OCF Ratio | -283.75 | -164.37 | -201.89 | 0.00 | n/a | n/a | -0.00 | -15.49 | -16.89 | -35.36 | -33.23 | -155.95 | -82.55 | -66.6 | -18.96 | -71.05 | -55.14 | -60.55 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.08 | 0.08 | 0.04 | 0.03 | n/a | 0.17 | 0.12 | 0.11 | 0.10 | 0.10 | 0.10 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
Quick Ratio | 0.13 | 0.06 | 0.08 | 0.07 | n/a | 0.17 | 0.23 | 0.33 | 0.48 | 1.14 | 1.48 | 1.56 | 2.36 | 12.77 | 11.08 | 3.49 | 2.57 | 7.29 |
Current Ratio | 0.13 | 0.06 | 0.08 | 0.07 | n/a | 0.17 | 0.23 | 0.33 | 0.48 | 1.14 | 1.48 | 1.56 | 2.36 | 12.77 | 11.08 | 3.49 | 2.57 | 7.29 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 22.02 | 45.97 | 213.36 | 50.07 | 169.02 | 15.53 | 66.44 | -15.34 | -47.02 | -75.23 | -1.04K | -42.38 | -67.8 | -83.63 | -145.44 | -31.7 | -35.38 | -30.97 |
Return on Equity | n/a | -0.09 | -0.45 | 335.01K | n/a | -0.1 | -0.85 | -5.85K | -0.07 | -0.12 | -2.42 | -0.04 | -0.04 | -0.06 | -0.1 | -0.02 | -0.02 | -0.01 |
Return on Assets | n/a | -0.07 | -0.36 | 271.03K | n/a | -0.08 | -0.67 | -4.92K | -0.06 | -0.1 | -2.07 | -0.03 | -0.04 | -0.06 | -0.09 | -0.02 | -0.02 | -0.01 |
Return on Invested Capital | -0.04 | -0.05 | -0.52 | 315.45K | n/a | -0.08 | -0.73 | -4.97K | -0.06 | -0.1 | -2.4 | -0.02 | -0.03 | -0.04 | -0.08 | -0.02 | -0.02 | -0.02 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |